Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-10-01FDA Approved: ONDANSETRON — Supplemental Application (AvPAK)
The FDA approved a supplemental application for ondansetron submitted by AvPAK.
-
FDA approval · 2021-10-01FDA Approved: ONDANSETRON — Supplemental Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare, Inc.'s supplemental application for ondansetron, indicating an approved change to the product's labeling.
-
FDA approval · 2021-09-28FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approves Cosette Pharmaceuticals' prochlorperazine edisylate as an original generic application for use as an antiemetic.
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: Dexamethasone Dose for Postoperative Nausea and Vomiting Prophylaxis in Obese Patients [Phase 4]
Phase 4 clinical trial update evaluating dexamethasone dose for preventing postoperative nausea and vomiting in obese patients.
-
FDA approval · 2021-09-01FDA Approved: ONDANSETRON — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for ondansetron by Hospira, Inc., a generic antiemetic. Ondansetron is used to prevent postoperative…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-09-01FDA Approved: ONDANSETRON — Supplemental Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for ondansetron submitted by Qilu Pharmaceutical Co., Ltd. (ANDA 203711).
-
FDA approval · 2021-08-19FDA Approved: ONDANSETRON — Supplemental Application (Eugia US LLC)
FDA approved a supplemental ANDA from Eugia US LLC for ondansetron hydrochloride (ondansetron), establishing a generic product.
-
FDA approval · 2021-08-19FDA Approved: ONDANSETRON — Supplemental Application (Eugia US LLC)
FDA approves a supplemental application for ondansetron hydrochloride (Ondansetron) submitted by Eugia US LLC.
-
FDA approval · 2021-08-16FDA Approved: ONDANSETRON — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for ondansetron by Hikma Pharmaceuticals USA Inc., confirming the continued availability/approval of…
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: High-Dose Steroid for Hip Arthroplasty Patients Expected to Have Postoperative Pain [Phase 4]
Phase 4 trial update evaluating high-dose steroids for reducing postoperative pain after hip arthroplasty; study completed.
-
FDA approval · 2021-06-29FDA Approved: PALONOSETRON HYDROCHLORIDE — Original Application (Avenacy, Inc.)
FDA approved palonosetron hydrochloride under an Original Abbreviated New Drug Application for Avenacy, Inc.
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: A COMPARATIVE STUDY BETWEEN 1MG AND 3 MG OF GRANISETRON IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING IN STRABISMUS OPHTHALMIC SURGERIES DURING GENERAL ANESTHESIA [Phase 3]
Phase 3 trial comparing 1 mg vs 3 mg granisetron for prevention of postoperative nausea and vomiting in strabismus ophthalmic surgery under …
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: Opioid Sparing Anaesthesia for Prevention of Postoperative Nausea and Vomiting in Laparoscopic Gynecological Surgery [Phase 4]
Phase 4 trial update evaluating opioid-sparing anesthesia to prevent postoperative nausea and vomiting in laparoscopic gynecologic surgery.
-
FDA approval · 2021-05-25FDA Approved: BARHEMSYS — Supplemental Application (Acacia Pharma Ltd)
The FDA approved a supplemental application for BARHEMSYS (amisulpride) submitted by Acacia Pharma Ltd.
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Granisteron Versus Metoclopramide in Laparoscopic Cholecystectomy [Phase 4]
Phase 4 trial comparing granisteron to metoclopramide for postoperative nausea and vomiting in laparoscopic cholecystectomy; current status …
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Simplified Algorithm for the Prevention of Postoperative Nausea and Vomiting in an Oncological Hospital [Phase 2]
Phase 2 trial updating a simplified algorithm to prevent postoperative nausea and vomiting in cancer patients; completed study.
-
EMA withdrawal · 2021-03-19EMA Application withdrawn: Dexamethasone Taw (Dexamethasone (sodium phosphate)) — Taw Pharma (Ireland) Ltd
EMA withdrew the application for Dexamethasone Taw (dexamethasone sodium phosphate) by Taw Pharma (Ireland) Ltd.
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Pilot Study to Assess Palonosetron Versus Ondansetron as Rescue Medication in Subjects That Develop Postoperative Nausea and Vomiting (PONV) in the Postanesthesia Care Unit (PACU) [Phase 2]
A Phase 2 pilot study comparing palonosetron to ondansetron as rescue medication for postoperative nausea and vomiting in the PACU has compl…
-
FDA approval · 2020-12-23FDA Approved: APREPITANT — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for aprepitant submitted by Sandoz Inc.
-
CLINICAL_TRIALS research · 2020-10-28Clinical Trial Update: Pharmacogenomics and Post-Operative Nausea and Vomiting [Phase 4]
Phase 4 trial update exploring pharmacogenomics in postoperative nausea and vomiting; results posted after completion.
-
FDA approval · 2020-10-21FDA Approved: PALONOSETRON HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for palonosetron hydrochloride by Sandoz Inc under ANDA 202521. The approval confirms the generic pr…
-
FDA approval · 2020-10-21FDA Approved: APREPITANT — Original Application (Golden State Medical Supply, Inc.)
FDA approved the original application for aprepitant, granting a generic version of this antiemetic to expand access.
-
CLINICAL_TRIALS trial_result · 2020-10-06Clinical Trial Update: Palonosetron Versus Ondansetron for PONV Prevention in Patients Undergoing ERCP [Phase 4]
Clinical trial comparing palonosetron to ondansetron for prevention of postoperative nausea and vomiting in patients undergoing ERCP (Phase …
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: A Comparison of Tumescence in Breast Reduction Surgery [Phase 4]
Phase 4 clinical trial comparing tumescence in breast reduction surgery; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-09-30Clinical Trial Update: Granisetron vs Granisetron and Dexamethasone on the Reduction of Postoperative Nausea and Vomiting [Phase 2]
Phase 2 trial comparing granisetron alone versus granisetron plus dexamethasone for reduction of postoperative nausea and vomiting (PONV).